Genotypic differences between C57BL/6 and a inbred mice in anxiolytic and sedative actions of diazepam

Behavior Genetics

Volumn 28, Issue 2, 1998, Pages 125-136

  Garrett, Kennon M ^a   Niekrasz, Iwona ^a   Haque, Dewan ^a   Parker, K Michael ^b   Seale, Thomas W ^a,b  

^a Department of Physiology ^*

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Anxiety; Benzodiazepines; GABA(A) receptor; Inbred mice; Pharmacogenetics; Sedation

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; DIAZEPAM; FLUMAZENIL; SEDATIVE AGENT; SEROTONIN 1A AGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG RECEPTOR BINDING; GABAERGIC SYSTEM; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INBRED STRAIN; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MOUSE; NONHUMAN; PSYCHOPHARMACOLOGY; SEDATION; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; AROUSAL; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENOTYPE; MALE; MAZE LEARNING; MICE; MICE, INBRED A; MICE, INBRED C57BL; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SPECIES SPECIFICITY;

ANIMALIA;

EID: 0031970231     PISSN: 00018244     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021424108213     Document Type: Article

References (48)

1. Baldessarini, R. J. (1995). Drugs and the treatment of psychiatric disorders: Psychosis and anxiety. In Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., and Gillman, A. G. (eds.), The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, pp. 399-430.
2. Cao, W., Burkholder, T., Wilkins, L., and Collins, A. C. (1993). A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacol. Biochem. Behav. 45:803-809.
3. Chapouthier, G., Bondoux, D., Martin, B., Desforges, C., and Launay, J. M. (1991). Genetic differences in sensitivity to beta-carbolines: Evidence for the involvement of brain benzodiazepine receptors. Brain Res. 553:342-346.
4. Cooper, S. J. (1985). Bidirectional control of palatable food consumption through a common benzodiazepine receptor: Theory and evidence. Brain Res. Bull. 15:397-410.
5. Crabbe, J. C., and Belknap, J. K. (1992). Genetic approaches to drug dependence. Trends Neurosci. 13:212-219.
6. Crawley, J. N., and Davis, L. G. (1982). Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains. Brain. Res. Bull. 8:609-612.
7. Davies, M. F., Onaivi, E. S., Chen, S.-W., Maguire, P. A., Tsai, N. F., and Loew, G. H. (1994). Evidence for central benzodiazepine receptor heterogeneity from behavior tests. Pharmacol. Biochem. Behav. 49:47-56.
8. Eison, A. S., and Eison, M. S. (1994). Serotonergic mechanisms in anxiety. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 18:47-62.
9. File, S. E., Greenblatt, D. J., Martin, I. L., and Brown, C. (1985). Long-lasting anticonvulsant effects of diazepam in different mouse strains: Correlations with brain concentrations and receptor occupancy. Psychopharmacology 86:137-141.
10. Gallaher, E. J., Hollister, L. E., Gionet, S. E., and Crabbe, J. C. (1987). Mouse lines selected for genetic differences in diazepam sensitivity. Psychopharmacology 93:25-30.
11. Gallaher, E. J., Gionet, S. E., and Feller, D. J. (1991). Behavioral and neurochemical studies in diazepam-sensitive and -resistant mice. J. Addict. Dis. 10:45-60.
12. Gora-Maslak, G., McClearn, G. E., Crabbe, J. C., Phillips, T. J., Belknap, J. K., and Plomin, R. (1991). Use of recombinant inbred strains to identify quantitative trait loci in Psychopharmacology. Psychopharmacology 104:413-424.
13. Greenblatt, D. J., Shader, R. I., and Abemethy, D. R. (1983). Drug therapy. Current status of benzodiazepines. N. Engl. J. Med. 309:410-416.
14. Hendel, J., Elsass, P., Sorensen, K. H., Moller, I. W., Hvidberg, E. F., and Hansen, T. (1980). Anxiety and sedation during a stressful situation after a single dose of diazepam versus N-desmethyldiazepam - A controlled study. Psychopharmacology 70:303-305.
15. Hirsch, J. D., Garrett, K. M., and Beer, B. (1985). Heterogeneity of benzodiazepine binding sites: A review of recent research. Pharmacol. Biochem. Behav. 23:681-685.
16. Hobbs, W. R., Rall, T. W., and Verdoom, T. A. (1995). Hypnotics, sedatives: Ethanol. In Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., and Gillman, A. G. (eds.), The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, pp. 361-396.
17. Kaplan, S. A., and Jack, M. L. (1981). Pharmacokinetics and metabolism of anxiolytics. In Hoffmeister, F., and Stille, G. (eds.), Psychotropic Agents Part II: Anxiolytics, Gerontopsychopharmacological Agents and Psychomotor Stimulants, Springer-Verlag, New York, pp. 321-358.
18. Klepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C., and Beer, B. (1979). Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol. Biochem. Behav. 11:457-462.
19. Lister, R. G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185.
20. Logan, L., Scale, T. W., and Carney, J. M. (1986). Inherent difference in response to methyl xanthines among inbred mouse strains. Pharmacol. Biochem Behav. 24:1281-1286.
21. A receptor channels. Annu. Rev. Neurosci. 17:569-602.
22. Marcucci, F., Guaitani, A., Kvetina, J., Mussini, E., and Garattini, S. (1968). Species difference in diazepam metabolism and anticonvulsant effect. Eur. J. Pharmacol. 4: 467-470.
23. Marley, R. J., Freund, R. K., and Wehner, J. M. (1988). Differential response to flurazepam in long-sleep and short-sleep mice. Pharmacol. Biochem. Behav. 31:453-458.
24. Martin, B., Desforges, C., and Chapouthier, G. (1991). Comparison between patterns of convulsions induced by two beta-carbolines in 10 inbred strains of mice. Neurosci. Lett. 133:73-76.
25. Mathis, C., Paul, S. M., and Crawley, J. N. (1994). Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice. Behav. Genet. 24: 171-180.
26. Mathis, C., Neumann, P. E., Gershenfeld, H., Paul, S. M., and Crawley, J. N. (1995). Genetic analysis of anxiety-related behaviors and responses to benzodiazepine related drugs in AXB and BXA recombinant inbred mouse strains. Behav. Genet. 25:557-568.
27. McIntyre, T. D., and Alpem, H. P. (1986). Thiopental, phenobarbital and chlordiazepoxide induce the same differences in narcotic reaction as ethanol in long-sleep and short-sleep selectively bred mice. Pharmacol. Biochem. Behav. 24:895-898.
28. Möhler, H., and Okada, T. (1977). Benzodiazepine receptor: demonstration in the central nervous system. Science 198: 849-851.
29. Moser, P. C. (1989). An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology 99:48-53.
30. Pauwels, P. J., Van Gompel, P., and Leysen, J. E. (1993). Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Biochem. Pharmacol. 45:375-383.
31. Pellow, S., and File, S. E. (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plusmaze: A novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24:525-529.
32. Pellow, S., Chopin, P., File, S. E., and Briley, M. (1985). Validation of open:closed arm entries in an elevated plusmaze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167.
33. Randall, L. O., Scheckel, C. L., and Banziger, R. F. (1965). Pharmacology of the metabolites of chlordiazepoxide and diazepam. Curr. Ther. Res. 7:590-606.
34. Sanger, D. J., Benavides, J., Perrault, G., Morel, E., Cohen, C., Joly, D., and Zivkovic, B. (1994). Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypes. Neurosci. Biobehav. Rev. 3:355-372.
35. Seale, T. W., Abla, K. A., Roderick, T. H., Rennert, O. M., and Carney, J. M. (1987a). Different genes specify hyporesponsiveness to seizures induced by caffeine and the benzodiazepine inverse agonist, DMCM. Pharmacol. Biochem. Behav. 27:451-456.
36. Seale, T. W., Carney, J. M., Flux, M., Rennert, O. M., and Skolnick, P. (1987b). Coincident susceptibility to seizures induced by caffeine and the benzodiazepine inverse agonist, DMCM, in SWR and CBA inbred mice. Pharmacol. Biochem. Behav. 26:381-387.
37. Seale, T. W., Roderick, T., and Skolnick, P. (1987c). Ontogeny of susceptibility to the convulsant, RO 5-4864, and its relationship to audiogenic seizure susceptibility in inbred mice. Life Sci. 40:1267-1276.
38. Seale, T. W., Abla, K. A., Shamin, M. T., Carney, J. M., and Daly, J. W. (1988). 3,7-Dimethyl-1-propargylxanthine: A potent and relative in vivo antagonist for adenosine analogs. Life Sci. 43:1671-1684.
39. Seale, T. W., Niekrasz, I., and Garrett, K. M. (1996). Anxiolysis by ethanol, diazepam and buspirone in a novel murine behavioral assay. Neuroreport 7:1803-1808.
40. Shader, R. I., and Greenblatt, D. J. (1993). Use of benzodiazepines in anxiety disorders. N. Engl. J. Med. 328:1398-1405.
41. Squires, R. F., and Braestrup, C. (1977). Benzodiazepine receptors in rat brain. Nature 266:732-734.
42. Study, R. E., and Barker, J. L. (1981). Diazepam and (-)-pentobarbital: Fluctuation analysis reveals different mechanisms for potentiation of γ-aminobutyric acid responses in cultured central neurons. Proc. Natl. Acad. Sci. USA 78:7180-7184.
43. Sussman, N. (1993). Treating anxiety while minimizing abuse and dependence. J. Clin. Psychiat. 54(Suppl.):44-51.
44. Suzuki, T., Lu, M. S., Montegi, M., Yoshii, T., and Misawa, M. (1992). Genetic differences in the development of physical dependence upon diazepam in Lewis and Fisher 344 inbred rat strains. Pharmacol. Biochem. Behav. 43: 387-393.
45. Toubas, P. L., Abla, K. A., Cao, W., and Seale, T. W. (1990). Latency to enter a mirrored chamber: A novel behavioral assay for anxiolytic agents. Pharmacol. Biochem. Behav. 35:121-126.
46. Trullas, R., and Skolnick, P. (1993). Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology 111:323-331.
47. Van der Laan, J. W., de Boer, S. F., Van der Gugten, J., and de Groot, G. (1991). Differences in the duration of sedative and anxiolytic effects of desmethyl diazepam in two outbred Wistar strains. Pharmacol. Biochem. Behav. 39: 149-153.
48. Woods, S. W., and Charney, D. S. (1988). Benzodiazepines. A review of benzodiazepine treatment of anxiety disorders: pharmacology, efficacy and implications for pathophysiology. In Last, C. G., and Hersen, M. (eds.), Handbook of Anxiety Disorders, Pergamon Press, New York, pp. 413-444.